Lifecare Q4 2023: Setting the stage - Redeye

Redeye makes minor upwards adjustments to its fair value range following Lifecare’s year-end report 2023. With a recently reinforced balance sheet the company stands before an eventful year ahead, which should include both automated production and launch of a veterinary product.

Länk till analysen i sin helhet: https://www.redeye.se/research/986905/lifecare-q4-2023-setting-the-stage?utm_source=finwire&utm_medium=RSS